vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP (NEN). Click either name above to swap in a different company.
NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP is the larger business by last-quarter revenue ($23.6M vs $13.8M, roughly 1.7× Gossamer Bio, Inc.). Gossamer Bio, Inc. runs the higher net margin — -342.3% vs -677.3%, a 335.0% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 15.7%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
New England Realty Associates Limited Partnership is a real estate investment entity that owns, operates and manages residential and commercial properties primarily across the U.S. New England region. Its core assets include multifamily apartments, mixed-use properties and small commercial spaces, serving tenants across Massachusetts, New Hampshire and adjacent states, delivering steady returns to unitholders via rental income and property value growth.
GOSS vs NEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $23.6M |
| Net Profit | $-47.2M | $-1.4M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 14.0% |
| Net Margin | -342.3% | -677.3% |
| Revenue YoY | 47.1% | 15.7% |
| Net Profit YoY | -43.0% | -133.0% |
| EPS (diluted) | $-0.21 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $23.6M | ||
| Q3 25 | $13.3M | $23.7M | ||
| Q2 25 | — | $21.2M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | — | $20.2M | ||
| Q2 24 | $95.8M | $20.1M | ||
| Q1 24 | $0 | $19.9M |
| Q4 25 | $-47.2M | $-1.4M | ||
| Q3 25 | $-48.2M | $-521.8K | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $3.8M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $49.2M | $4.1M | ||
| Q1 24 | $-41.9M | $3.5M |
| Q4 25 | -333.6% | 14.0% | ||
| Q3 25 | -369.4% | 20.0% | ||
| Q2 25 | — | 33.3% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | — | 32.0% | ||
| Q2 24 | 54.3% | 32.6% | ||
| Q1 24 | — | 28.9% |
| Q4 25 | -342.3% | -677.3% | ||
| Q3 25 | -362.7% | -2.2% | ||
| Q2 25 | — | 19.5% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 20.7% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | 51.4% | 20.3% | ||
| Q1 24 | — | 17.4% |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $26.7M |
| Total DebtLower is stronger | — | $531.0M |
| Stockholders' EquityBook value | $-122.8M | — |
| Total Assets | $172.2M | $505.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $26.7M | ||
| Q3 25 | $180.2M | $13.4M | ||
| Q2 25 | — | $16.7M | ||
| Q1 25 | — | $30.9M | ||
| Q4 24 | — | $17.6M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | $354.5M | $13.5M | ||
| Q1 24 | $244.4M | $28.8M |
| Q4 25 | — | $531.0M | ||
| Q3 25 | — | $514.2M | ||
| Q2 25 | — | $514.3M | ||
| Q1 25 | — | $407.8M | ||
| Q4 24 | — | $408.6M | ||
| Q3 24 | — | $409.3M | ||
| Q2 24 | — | $410.0M | ||
| Q1 24 | — | $410.7M |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $81.5M | — | ||
| Q1 24 | $26.7M | — |
| Q4 25 | $172.2M | $505.3M | ||
| Q3 25 | $208.8M | $492.9M | ||
| Q2 25 | — | $494.8M | ||
| Q1 25 | — | $385.2M | ||
| Q4 24 | — | $393.5M | ||
| Q3 24 | — | $387.4M | ||
| Q2 24 | $373.4M | $383.7M | ||
| Q1 24 | $259.4M | $381.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $27.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $27.7M | ||
| Q3 25 | $-36.2M | $2.3M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $5.5M | ||
| Q4 24 | — | $31.9M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | $116.3M | $5.4M | ||
| Q1 24 | $-52.3M | $6.1M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.02× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 7.57× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | 2.36× | 1.32× | ||
| Q1 24 | — | 1.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
